Kentaro Ito

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Ejection Fraction

Patient Reported Outcomes

Epidermal Growth Factor Receptor

Advanced Non Small Cell Lung Cancer

Top Venues

Thoracic cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Kentaro Ito, Miho Nishio, Kentaro Fujiwara, Yoichi Nishii, Kengo Ushiro, Hiroki Yasui, Osamu Hataji
Refractory response to entrectinib for ROS-1 rearranged NSCLC with concurrent de novo TP53 mutation showing good response to CNS lesion, but poor duration of response: A case report. Thoracic cancer (2023)
Shinya Sakata, Isamu Okamoto, Hisako Yoshida, Kentaro Ito, Atsushi Nakamura, Shunsuke Teraoka, Naohisa Matsumoto, Yoshimasa Shiraishi, Koji Haratani, Motohiro Tamiya, Satoshi Ikeda, Satoru Miura, Junko Tanizaki, Shota Omori, Hiroshige Yoshioka, Akito Hata, Nobuyuki Yamamoto, Kazuhiko Nakagawa
Real-world data on NGS using the Oncomine DxTT for detecting genetic alterations in non-small-cell lung cancer: WJOG13019L. Cancer science (2021)
Yuta Adachi, Kentaro Ito, Yuko Hayashi, Ryo Kimura, Tuan-Zea Tan, Rui Yamaguchi, Hiromichi Ebi
Epithelial-to-Mesenchymal Transition is a Cause of Both Intrinsic and Acquired Resistance to KRAS G12C Inhibitor in KRAS G12C-Mutant Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (22) (2020)
Kentaro Ito, Kenta Murotani, Akihito Kubo, Eiji Kunii, Hirokazu Taniguchi, Joe Shindoh, Kazuhiro Asada, Kazuyoshi Imaizumi, Kosuke Takahashi, Masato Karayama, Motoyasu Okuno, Naoki Inui, Osamu Hataji, Sayako Morikawa, Shunsaku Hayai, Takafumi Suda, Takashi Abe, Takeshi Tsuda, Teppei Yamagichi, Tomoki Kimura, Yuko Oya, Tatsuya Yoshida, Toyoaki Hida
Propensity score analysis of overall survival between first- and second-generation EGFR-TKIs using real-world data. Cancer science 111 (10) (2020)